Ludwig H; Avet-Loiseau H; Bladé J; Boccadoro M; Cavenagh J; Cavo M; Davies F; de la Rubia J; Delimpasi S; Dimopoulos M; Drach J; Einsele H; Facon T; Goldschmidt H; Hess U; Mellqvist UH; Moreau P; San-Miguel J; Sondergeld P; Sonneveld P; Udvardy M; Palumbo A., European perspective on multiple myeloma treatment strategies: update following recent congresses., «THE ONCOLOGIST», 2012, 17, pp. 592 - 606 [articolo]
Alessandro Gozzetti; Alfonso Cerase; Flavia Lotti; Davide Rossi; Antonio Palumbo; Maria Teresa Petrucci; Francesca Patriarca; Chiara Nozzoli; Michele Cavo; Massimo Offidani; Michele Floridia; Salvatore Berretta; Roberto Vallone; Pellegrino Musto; Francesco Lauria; and for the GIMEMA (Gruppo Italiano Malattie Ematologiche dell'Adulto) Myeloma Working Party; additional authors who participated to the study: Elena Marchini; Alberto Fabbri; Stefania Oliva; Elena Zamagni; Fabiana Gentilini; Stelvio Ballanti; Giuseppe Mele; Monica Galli; Maria Teresa Pirrotta; Francesco Di Raimondo, Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: a retrospective survey of 50 patients, «CANCER», 2012, 118, pp. 1574 - 1584 [articolo]
Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M., Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5, in: Suppl. 1, Chicago, «CANCER RESEARCH», 2012, 72, pp. 1873 - 1873 (atti di: AACR 2012 Annual Meeting, Chicago, 30 March - 04 April 2012) [atti di convegno-abstract]
G Perrone; E Borsi; C Terragna; M Martello; M Mancini; M Aluigi; MA Santucci; G Martinelli; M Baccarani; M Cavo, HIF-1a INHIBITION PROMOTES CELL CYCLE ARREST IN MULTIPLE MYELOMA, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 105 - 105 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M., High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 240 - 240 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Cavo, M; Sonneveld, P; Moreau, P; Blade, J; Goldschmidt, H; San Miguel, JF; Attal, M; Avet-Loiseau, H; Blau, WI; Facon, T; Gutierrez, N; Harousseau, JL; van der Holt, B; Jose Lahuerta, J; Lokhorst, H; Marit, G; Luisa Martin, M; Marzocchi, G; Palumbo, A; Patriarca, F; Petrucci, MT; Rosinol, L; Salwender, H; Terragna, C, Impact of Bortezomib Incorporated Into Autotransplantation On Outcomes of Myeloma Patients with High-Risk Cytogenetics: An Integrated Analysis of 1894 Patients Enrolled in Four European Phase 3 Studies, in: Blood, 2012, pp. 749 - 749 (atti di: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012) [atti di convegno-abstract]
Ludwig H, Durie BG, McCarthy P, Palumbo A, San Miguel J, Barlogie B, Morgan G, Sonneveld P, Spencer A, Andersen KC, Facon T, Stewart KA, Einsele H, Mateos MV, Wijermans P, Waage A, Beksac M, Richardson PG, Hulin C, Niesvizky R, Lokhorst H, Landgren O, Bergsagel PL, Orlowski R, Hinke A, Cavo M, Attal M; International Myeloma Working Group., IMWG consensus on maintenance therapy in multiple myeloma., «BLOOD», 2012, 119, pp. 3003 - 3015 [articolo]
Brioli A;Zamagni E;Pasquali S;Tosi P;Tacchetti P;Perrone G;Pantani L;Petrucci A;Zannetti BA;Baccarani M;Cavo M, Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1248 - 1249 [articolo]
Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M., Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 419 - 426 [articolo]
Richardson PG; Delforge M; Beksac M; Wen P; Jongen JL; Sezer O; Terpos E; Munshi N; Palumbo A; Rajkumar SV; Harousseau JL; Moreau P; Avet-Loiseau H; Lee JH; Cavo M; Merlini G; Voorhees P; Chng WJ; Mazumder A; Usmani S; Einsele H; Comenzo R; Orlowski R; Vesole D; Lahuerta JJ; Niesvizky R; Siegel D; Mateos MV; Dimopoulos M; Lonial S; Jagannath S; Bladé J; Miguel JS; Morgan G; Anderson KC; Durie BG; Sonneveld P., Management of treatment-emergent peripheral neuropathy in
multiple myeloma., «LEUKEMIA», 2012, 26, pp. 595 - 608 [articolo]
Morgan G; Johnsen HE; Goldschmidt H; Palumbo A; Cavo M; Sonneveld P; Miguel JS; Chim CS; Browne P; Einsele H; Waage A; Turesson I; Spencer A; Hajek R; Ludwig H; Hemminki K; Houlston R., MyelomA Genetics International Consortium., «LEUKEMIA & LYMPHOMA», 2012, 53, pp. 796 - 800 [articolo]
Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F;
Bochicchio GB; Cavo M; Boccadoro M; Palumbo A, Primary plasma cell leukemia in the era of new drugs: has something changed?, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2012, 82, pp. 141 - 149 [articolo]
Moreau P; Richardson PG; Cavo M; Orlowski RZ; San Miguel JF; Palumbo A; Harousseau JL., Proteasome inhibitors in multiple myeloma: ten years later., «BLOOD», 2012, --, pp. 1 - 47 [articolo]
Kumar S.K.; Lee J.H.; Lahuerta J.J.; Morgan G.; Richardson P.G.; Crowley J.; Haessler J.; Feather J.; Hoering A.; Moreau P.; LeLeu X.; Hulin C.; Klein S.K.; Sonneveld P.; Siegel D.; Bladé J.; Goldschmidt H.; Jagannath S.; Miguel J.S.; Orlowski R.; Palumbo A.; Sezer O.; Rajkumar S.V.; Durie B.G. International Myeloma Working Group
Abildgaard N; Abonour R; Alexanian R; Alsina M; Anderson KC; Attal M; Avet-Loiseau H; Badros A; Baris D; Barlogie B; Bataille R; Beksaç M; Belch A; Ben-Yehuda D; Bensinger B; Bergsagel PL; Bird J; Bladé J; Boccadoro M; Cavo M; Chanan-Khan A; Chen WM; Child T; Chim J; Chng WJ; Comenzo R; Crowley J; Dalton W; Davies F; de Souza C; Delforge M; Dimopoulos M; Dispenzieri A; Drach J; Drake M; Durie BG; Einsele H; Facon T; Fantl D; Fermand JP; Fonseca R; Gahrton G; García-Sanz R; Gasparetto C; Gertz M; Gibson J; Giralt S; Goldschmidt H; Greipp P; Hajek R; Hardan I; Hari P; Harousseau JL; Hata H; Hattori Y; Heffner T; Ho J; Hungria V; Ida S; Jacobs P; Jagannath S, Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study., «LEUKEMIA», 2012, 26, pp. 149 - 157 [articolo]
Barosi G; Merlini G; Billio A; Boccadoro M; Corradini P; Marchetti M; Massaia M; Tosi P; Palumbo A; Cavo M; Tura S., SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 875 - 888 [articolo]
